Autoantibodies
"Autoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
Descriptor ID |
D001323
|
MeSH Number(s) |
D12.776.124.486.485.114.323 D12.776.124.790.651.114.323 D12.776.377.715.548.114.323
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Autoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Autoantibodies".
This graph shows the total number of publications written about "Autoantibodies" by people in this website by year, and whether "Autoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 1 | 4 | 1996 | 4 | 3 | 7 | 1997 | 0 | 2 | 2 | 1998 | 1 | 2 | 3 | 1999 | 8 | 3 | 11 | 2000 | 3 | 1 | 4 | 2001 | 1 | 2 | 3 | 2002 | 6 | 1 | 7 | 2003 | 5 | 4 | 9 | 2004 | 13 | 10 | 23 | 2005 | 7 | 8 | 15 | 2006 | 4 | 7 | 11 | 2007 | 14 | 8 | 22 | 2008 | 12 | 9 | 21 | 2009 | 16 | 16 | 32 | 2010 | 12 | 8 | 20 | 2011 | 23 | 9 | 32 | 2012 | 17 | 9 | 26 | 2013 | 25 | 9 | 34 | 2014 | 19 | 7 | 26 | 2015 | 17 | 18 | 35 | 2016 | 17 | 9 | 26 | 2017 | 22 | 20 | 42 | 2018 | 20 | 11 | 31 | 2019 | 21 | 17 | 38 | 2020 | 19 | 10 | 29 | 2021 | 15 | 18 | 33 | 2022 | 4 | 46 | 50 | 2023 | 4 | 43 | 47 | 2024 | 4 | 4 | 8 | 2025 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Autoantibodies" by people in Profiles.
-
Karakus KE, Fleury T, Baschal EE, McDaniel KA, Choi H, Armstrong TK, Yu L, Simmons KM, Michels AW. Clinical Features and HLA Genetics Differ in Children at Type 1 Diabetes Onset by Hispanic Ethnicity. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):1187-1194.
-
Calhoun P, Spanbauer C, Steck AK, Frohnert BI, Herman MA, Keymeulen B, Veijola R, Toppari J, Desouter A, Gorus F, Atkinson M, Wilson DM, Pietropaolo S, Beck RW. Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development. Diabetologia. 2025 May; 68(5):930-939.
-
Holers VM, Demoruelle KM, Buckner JH, James EA, Firestein GS, Robinson WH, Steere AC, Zhang F, Norris JM, Kuhn KA, Deane KD. Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis. Nat Rev Rheumatol. 2024 Oct; 20(10):601-613.
-
Phillip M, Achenbach P, Addala A, Albanese-O'Neill A, Battelino T, Bell KJ, Besser REJ, Bonifacio E, Colhoun HM, Couper JJ, Craig ME, Danne T, de Beaufort C, Dovc K, Driscoll KA, Dutta S, Ebekozien O, Larsson HE, Feiten DJ, Frohnert BI, Gabbay RA, Gallagher MP, Greenbaum CJ, Griffin KJ, Hagopian W, Haller MJ, Hendrieckx C, Hendriks E, Holt RIG, Hughes L, Ismail HM, Jacobsen LM, Johnson SB, Kolb LE, Kordonouri O, Lange K, Lash RW, Lernmark ?, Libman I, Lundgren M, Maahs DM, Marcovecchio ML, Mathieu C, Miller KM, O'Donnell HK, Oron T, Patil SP, Pop-Busui R, Rewers MJ, Rich SS, Schatz DA, Schulman-Rosenbaum R, Simmons KM, Sims EK, Skyler JS, Smith LB, Speake C, Steck AK, Thomas NPB, Tonyushkina KN, Veijola R, Wentworth JM, Wherrett DK, Wood JR, Ziegler AG, DiMeglio LA. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetologia. 2024 Sep; 67(9):1731-1759.
-
Phillip M, Achenbach P, Addala A, Albanese-O'Neill A, Battelino T, Bell KJ, Besser REJ, Bonifacio E, Colhoun HM, Couper JJ, Craig ME, Danne T, de Beaufort C, Dovc K, Driscoll KA, Dutta S, Ebekozien O, Elding Larsson H, Feiten DJ, Frohnert BI, Gabbay RA, Gallagher MP, Greenbaum CJ, Griffin KJ, Hagopian W, Haller MJ, Hendrieckx C, Hendriks E, Holt RIG, Hughes L, Ismail HM, Jacobsen LM, Johnson SB, Kolb LE, Kordonouri O, Lange K, Lash RW, Lernmark ?, Libman I, Lundgren M, Maahs DM, Marcovecchio ML, Mathieu C, Miller KM, O'Donnell HK, Oron T, Patil SP, Pop-Busui R, Rewers MJ, Rich SS, Schatz DA, Schulman-Rosenbaum R, Simmons KM, Sims EK, Skyler JS, Smith LB, Speake C, Steck AK, Thomas NPB, Tonyushkina KN, Veijola R, Wentworth JM, Wherrett DK, Wood JR, Ziegler AG, DiMeglio LA. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care. 2024 Aug 01; 47(8):1276-1298.
-
Borgers JSW, van Wesemael TJ, Gelderman KA, Rispens T, Verdegaal EME, Moes DJAR, Korse CM, Kapiteijn E, Welters MJP, van der Burg SH, van Houdt WJ, van Thienen JV, Haanen JBAG, van der Woude D. Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma. J Immunother Cancer. 2024 Jun 30; 12(6).
-
O'Neil LJ, Alp?zar-Rodr?guez D, Deane KD. Rheumatoid Arthritis: The Continuum of Disease and Strategies for Prediction, Early Intervention, and Prevention. J Rheumatol. 2024 Apr 01; 51(4):337-349.
-
Fiske BE, Getahun A. Failed Downregulation of PI3K Signaling Makes Autoreactive B Cells Receptive to Bystander T Cell Help. J Immunol. 2024 Apr 01; 212(7):1150-1160.
-
Virostko J, Wright JJ, Williams JM, Hilmes MA, Triolo TM, Broncucia H, Du L, Kang H, Nallaparaju S, Valencia LG, Reyes D, Hammel B, Russell WE, Philipson LH, Waibel M, Kay TWH, Thomas HE, Greeley SAW, Steck AK, Powers AC, Moore DJ. Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes. Diabetes Care. 2024 Mar 01; 47(3):393-400.
-
Yandamuri SS, Filipek B, Lele N, Cohen I, Bennett JL, Nowak RJ, Sotirchos ES, Longbrake EE, Mace EM, O'Connor KC. A Noncanonical CD56dimCD16dim/- NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases. J Immunol. 2024 Mar 01; 212(5):785-800.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|